Search

everythinglearnresearchcommunity

for

Search:↓

Estrogen-progestin contraception lowers ovarian, endometrial, and colon cancer risk but may raise breast and cervical cancer risk, helps with menstrual and acne issues, and new methods are as effective as pills. Metformin helps overweight women with PCOS and insulin resistance, and dopamine agonists treat prolactinomas.

Scientists at the University of Michigan Medical School successfully created a special compound that can be used to improve imaging of prostate cancer.

GI198745 is more potent and longer-lasting than finasteride, potentially better for treating hair loss.

A peptide known for reducing wrinkles also effectively inhibits an enzyme linked to skin inflammation and acne.

New compounds were made and tested, with compound 6 showing potential for treating prostate-related diseases.

Blocking a certain signal in the gp130 receptor can improve tissue healing and lessen osteoarthritis symptoms.

Triphenylphosphine oxide can increase oil production and reduce inflammation in skin cells without affecting TRPM5.

New curcumin analogues help fight prostate cancer by breaking down androgen receptors.

Selective Androgen Receptor Modulators (SARMs) are drugs that can control the effects of androgens in different tissues, potentially having fewer side effects and promising for treating various conditions.

Retinoids increase steroid sulfatase activity in leukemia cells through RARα/RXR and involves certain pathways like phosphoinositide 3-kinase and ERK-MAP kinase.

Total glucosides of paeony may help treat alopecia areata by reducing inflammation and hair loss.

MR antagonists may improve skin health and wound healing, especially in aging.

Progesterone affects GABA_A receptor function by altering δ subunit levels.

Progesterone and its byproducts control a specific receptor in the brain independently of progesterone receptors, affecting conditions related to the menstrual cycle.

Certain drugs are effective for skin conditions like psoriasis, vitiligo, and hair loss.

AHR ligands could treat inflammatory skin diseases.

Antiandrogens affect androgen-dependent body functions and are used for various medical conditions, with some risks like fetus feminization, but new forms like 17α-propylmesterolone show promise for acne without systemic effects.

GnRH analogues are effective for diagnosing and treating female androgen excess, offering a non-surgical option.

Newer retinoid drugs are effective for skin conditions but have significant side effects.

Polyunsaturated fatty acids, especially arachidonic acid and eicosapentaenoic acid, can promote hair growth.

The treatment effectively reduced hair growth and was safe for patients with PCOS, but it needs better bleeding control.

The new compound is a promising, less toxic alternative to finasteride for treating prostate issues.

Both metformin and pioglitazone improve PCOS symptoms, but pioglitazone is a good alternative for those who can't take metformin.

PF-998425 is a new, effective, and non-phototoxic treatment for skin conditions related to androgens.

Treating early puberty with hormone therapy may increase the risk of polycystic ovary syndrome in adults.

Some cannabinoid derivatives may be more effective than current drugs at targeting proteins relevant to prostate cancer treatment.

Activating δ-opioid receptors can help hair grow.

PDE inhibitors, especially PDE4 inhibitors like apremilast, are effective for certain inflammatory skin conditions but have side effects and can be costly.

Dihydrotestosterone changes some hormone-related gene expressions in rat pituitary glands but doesn't affect the estrous cycle.

Phosphatidic acid may promote hair growth like minoxidil.